Design of Magnetic Nanoplatforms for Cancer Theranostics

Biosensors (Basel). 2022 Jan 12;12(1):38. doi: 10.3390/bios12010038.

Abstract

Cancer is the top cause of death globally. Developing smart nanomedicines that are capable of diagnosis and therapy (theranostics) in one-nanoparticle systems are highly desirable for improving cancer treatment outcomes. The magnetic nanoplatforms are the ideal system for cancer theranostics, because of their diverse physiochemical properties and biological effects. In particular, a biocompatible iron oxide nanoparticle based magnetic nanoplatform can exhibit multiple magnetic-responsive behaviors under an external magnetic field and realize the integration of diagnosis (magnetic resonance imaging, ultrasonic imaging, photoacoustic imaging, etc.) and therapy (magnetic hyperthermia, photothermal therapy, controlled drug delivery and release, etc.) in vivo. Furthermore, due to considerable variation among tumors and individual patients, it is a requirement to design iron oxide nanoplatforms by the coordination of diverse functionalities for efficient and individualized theranostics. In this article, we will present an up-to-date overview on iron oxide nanoplatforms, including both iron oxide nanomaterials and those that can respond to an externally applied magnetic field, with an emphasis on their applications in cancer theranostics.

Keywords: cancer; iron oxide nanoparticles; magnetotheranostics.

Publication types

  • Review

MeSH terms

  • Humans
  • Magnetic Resonance Imaging
  • Nanoparticles*
  • Nanostructures*
  • Neoplasms* / therapy
  • Precision Medicine